Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Despite soaring demand for GLP-1s, many eligible patients are unable to access these drugs for weight loss

In just a few short years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged in popularity across the United States, transforming from specialized treatments for type 2 diabetes into revolutionary therapeutics for weight management, cardiovascular health and other emerging uses. But not all populations are benefiting from this expansion. As GLP-1 use has increased, disparities in…

Despite soaring demand for GLP-1s, many eligible patients are unable to access these drugs for weight loss

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

Report a problem with this story

More in Health & Medicine

More from Saturday 21 November →